Geriatrisches Zentrum

Zurück zum Hauptmenü
Zum Menü der Einrichtung

200
202
203
204
201

Adresse: Calwerstr. 14
72076 Tübingen

Telefonnummer: 07071 29-87517

Faxnummer: 07071 29-4628

Anfahrt Notfall

Publikationen von Mitarbeitern des GZ 2013

  • Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M.Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities.Lancet Neurol. 2013 May;12(5):514-24.
    Zum Abstract
  • Brockmann K, Schulte C, Hauser AK, Lichtner P, Huber H, Maetzler W, Berg D, Gasser T. SNCA: major genetic modifier of age at onset of Parkinson's disease. Mov Disord. 2013 Aug;28(9):1217-21.
    Zum Abstract
  • Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T, Monoranu CM.Neuron-Specific Alterations in Signal Transduction Pathways associated with Alzheimer's Disease.J Alzheimers Dis. 2013 Dec 13. [Epub ahead of print]
    Zum Abstract
  • Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T, Monoranu CM.
    Neuron-Specific Mitochondrial DNA Deletion Levels in Sporadic Alzheimer´s Disease. Curr Alzheimer Res. 2013 Dec;10(10):1041-6.
    Zum Abstract
  • Heinzel S, Metzger FG, Ehlis AC, Korell R, Alboji A, Haeussinger FB, Hagen K, Maetzler W, Eschweiler GW, Berg D, Fallgatter AJ; TREND Study Consortium.Aging-related cortical reorganization of verbal fluency processing: a functional near-infrared spectroscopy study.Neurobiol Aging. 2013 Feb;34(2):439-50.
    Zum Abstract
  • Heni M, Schöpfer P, Peter A, Sartorius T, Fritsche A, Synofzik M, Häring HU, Maetzler W, Hennige AM. Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans.Acta Diabetol. 2013 Dec 27. [Epub ahead of print]
    Zum Abstract
  • Jaeger S, Pfiffner C, Weiser P, Längle G, Croissant D, Schepp W, Kilian R, Becker T, Eschweiler G, Steinert T. Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion.Soc Psychiatry Psychiatr Epidemiol. 2013 Nov;48(11):1787-96.
    Zum Abstract
  • Koehler NK, Stransky E, Shing M, Gaertner S, Meyer M, Schreitmüller B, Leyhe T, Laske C, Maetzler W, Kahle P, Celej MS, Jovin TM, Fallgatter AJ, Batra A, Buchkremer G, Schott K, Richartz-Salzburger E.Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.PLoS One. 2013 May 31;8(5):e64649.
    Zum Abstract
  • Laske C.Blood-based biomarkers in Alzheimer disease: where are we now and where have we to go?JAMA Neurol. 2013 Jan;70(1):133. No abstract available.
  • Laske C, Schmohl M, Leyhe T, Stransky E, Maetzler W, Berg D, Fallgatter AJ, Joos T, Dietzsch J.Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients.J Alzheimers Dis. 2013 Jan  1;34(2):367-75.
    Zum Abstract
  • Laske C, Stellos K.Vascular Pathophysiology of Alzheimer`s Disease. Curr Alzheimer Res. 2013 Nov 19. [Epub ahead of print]
    No abstract available.
  • Leyhe T, Darreh-Shori T, Laske C, Mielke MM, Maetzler W.Biomarkers in Alzheimer's disease and lewy body disorders with dementia.Int J Alzheimers Dis. 2013;2013:473181.
    Zum Abstract
  • Liepelt-Scarfone I, Fruhmann Berger M, Prakash D, Csoti I, Gräber S, Maetzler W, Berg D. Clinical Characteristics with an Impact on ADL Functions of PD Patients with Cognitive Impairment Indicative of Dementia.PLoS One. 2013 Dec 9;8(12):e82902.
    Zum Abstract
  • Liepelt-Scarfone I, Gauss K, Maetzler W, Müller K, Bormann C, Fruhmann Berger M, Timmers M, Streffer J, Berg D.Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.Neuroepidemiology. 2013;41(3-4):174-82.
    Zum Abstract
  • Maetzler W, Nieuwhof F, Hasmann SE, Bloem BR.Emerging therapies for gait disability and balance impairment: promises and pitfalls.Mov Disord. 2013 Sep 15;28(11):1576-86.
    Zum Abstract
  • Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR.Quantitative wearable sensors for objective assessment of Parkinson's disease.Mov Disord. 2013 Oct;28(12):1628-37.
    Zum Abstract
  • Mielke A, Wirkus K, Niebler R, Eschweiler G, Nguyen NX, Trauzettel-Klosinski S. [The influence of visual rehabilitation on secondary depressive disorders due to age-related macu-lar degeneration. A randomized controlled pilot study]. Ophthalmologe. 2013 May; 110(5):433-40.
    Zum Abstract
  • Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, Gasser T, Hauser AK, Gräber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I.Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.PLoS One. 2013 Sep 18;8(9):e73094.
    Zum Abstract
  • Milian M, Leiherr AM, Straten G, Müller S, Leyhe T, Eschweiler GW. The Mini-Cog, Clock Drawing Test, and the Mini-Mental State Examination in a German memory clinic: specificity of separation dementia from depression. Int Psychogeriatr. 2013 Jan;25(1):96-104.
    Zum Abstract
  • Müller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T.Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.Mult Scler. 2013 May;19(6):799-805. Nov 19.
    Zum Abstract
  • Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E.A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.JAMA Neurol. 2013 Jun;70(6):727-35.
    Zum Abstract
  • Polak T, Zeller D, Fallgatter AJ, Metzger FG.Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.Neuroreport. 2013 Mar 27;24(5):251-3.
    Zum Abstract
  • Polak T, Dresler T, Zeller JB, Warrings B, Scheuerpflug P, Fallgatter AJ, Deckert J, Metzger FG.Vagus somatosensory evoked potentials are delayed in Alzheimer's disease, but not in major depression. Eur Arch Psychiatry Clin Neurosci. 2013 Jun 5. [Epub ahead of print]
    Zum Abstract
  • Sopova K, Gatsiou A, Stellos K, Laske C. Dysregulation of Neurotrophic and Haematopoietic Growth Factors in Alzheimer's Disease: From Pathophysiology to Novel Treatment Strategies. Curr Alzheimer Res. 2013 Nov 19. [Epub ahead of print]
    Zum Abstract
  • Tzikas S, Schlak D, Sopova K, Gatsiou K, Stakos D, Stamatelopoulos K, Stellos K, Laske C.Increased Myeloperoxidase Plasma Levels in Patients with Alzheimer's Disease. J Alzheimers Dis. 2013 Nov 5. [Epub ahead of print]
    Zum Abstract
  • Vijayaraghavan S, Maetzler W, Reimold M, Lithner CU, Liepelt-Scarfone I, Berg D, Darreh-Shori T.High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.Alzheimers Dement. 2013 Aug 23. pii: S1552-5260(13)02463-1.
    Zum Abstract

Zertifikate und Verbände

Focus: Top Nationales Krankenhaus 2024

Die deutschen Universitätsklinika

Kooperation für Transparenz und Qualität im Gesundheitswesen

Qualitätspartnerschaft mit der PKV

Blauer Sterne Betrieb

Erfolgsfaktor Familie

Die Altersvorsorge für den Öffentlichen Dienst